<DOC>
	<DOCNO>NCT02703220</DOCNO>
	<brief_summary>Sleep-disordered breathing ( SDB sleep apnea ) common among elderly Veterans lead increase morbidity mortality population . The proposal aim identity whether oxygen , finasteride acetazolamide effective reduce unstable breathe eliminate sleep apnea elderly via different mechanism . This proposal enhance investigator ' understanding pathway contribute development sleep apnea elderly . The investigator expect result obtain study positively impact health Veterans identify new treatment modality sleep apnea . A cumulative effect investigator ' research fulfill long-term goal improve quality life elderly Veterans suffer sleep apnea potential life-threatening complication .</brief_summary>
	<brief_title>Sleep Apnea Elderly</brief_title>
	<detailed_description>Sleep apnea-hypopnea syndrome ( SAHS ) high prevalence associate adverse cardiovascular consequence elderly Veterans . Positive airway pressure therapy deem cumbersome often associate non-adherence therapy . This proposal investigate whether alternative therapy develop modulate specific physiologic mechanisms ventilatory control . Specifically , investigator study whether intervention sustain hyperoxia ( Aim 1 ) , finasteride ( Aim 2 ) acetazolamide ( Aim 3 ) reduce breathe instability sleep reduce chemoresponsiveness and/or increase cerebrovascular reactivity order alleviate sleep disorder breathe elderly sleep apnea . The propose aim also allow u delineate key mechanism breathe instability elderly . The investigator envision result obtain project ultimately allow u develop novel alternative therapy sleep apnea elderly .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Acetazolamide</mesh_term>
	<mesh_term>Finasteride</mesh_term>
	<criteria>Adults 60 year old old , mild moderate sleep apnea AHI &gt; /=5 20/hr central , obstructive , mixed apnea hypopnea . For finasteride protocol elderly men criterion without hypogonadism ( testosterone level 300 ng/dL ) enrol . Patients severe sleep apnea ( AHI &gt; 20/hr ) Patients history prostate cancer Males hypogonadism History cardiac disease , include myocardial infarction Bypass surgery Atrial ventricular tachybradycardias Systolic congestive heart failure CheyneStokes respiration Current unstable angina Stroke Schizophrenia Untreated hypothyroidism Seizure disorder Preexisting renal failure liver disorder Failure give inform consent . Patients significant pulmonary disease history abnormal pulmonary function testing , include moderate obstructive/restrictive lung/chest wall disorder rest oxygen saturation &lt; 96 % supplemental oxygen Patients certain medication include : study drug sympathomimetics/parasympathomimetics respective blocker narcotic antidepressant antipsychotic agent central nervous system ( CNS ) alter medication current alcohol , tobacco recreational drug use Patients BMI &gt; 34kg/m2 exclude avoid effect morbid obesity pulmonary mechanic ventilatory control Elderly unstable gait mobility issue may preclude safe participation Individuals allergy finasteride acetazolamide exclude specific protocol Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>sleep apnea</keyword>
	<keyword>chemoresponsiveness</keyword>
	<keyword>cerebrovascular response</keyword>
	<keyword>hyperoxia</keyword>
	<keyword>acetazolamide</keyword>
	<keyword>finasteride</keyword>
	<keyword>apneic threshold</keyword>
	<keyword>carbon-dioxide reserve</keyword>
</DOC>